Dual Biologic Therapy in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Retrospective Study.
Magdalena WlazłoMonika MeglickaAnna WiernickaMarcin OsieckiJarosław KierkuśPublished in: Children (Basel, Switzerland) (2022)
Our clinical experience suggests that dual therapy may be an option for pediatric patients with moderate and severe courses of IBD with limited therapeutic options.